Atrial Natriuretic Factor
"Atrial Natriuretic Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.
| Descriptor ID |
D009320
|
| MeSH Number(s) |
D06.472.699.584.500 D12.644.548.585.500
|
| Concept/Terms |
Atrial Natriuretic Factor- Atrial Natriuretic Factor
- Auriculin
- ANP
- Natriuretic Peptides, Atrial
- ANF
- Atriopeptins
- Atrial Natriuretic Peptides
- Peptides, Atrial Natriuretic
alpha-Atrial Natriuretic Peptide- alpha-Atrial Natriuretic Peptide
- alpha Atrial Natriuretic Peptide
- ANP-(99-126)
- Atriopeptin (99-126)
- Cardionatrin I
- Atrial Natriuretic Factor (99-126)
- ANF (1-28)
- Atriopeptin (1-28)
- Atrial Natriuretic Factor (1-28)
- gamma ANP (99-126)
- alpha ANP
- Cardiodilatin (99-126)
- ANP Prohormone (99-126)
- ANF (99-126)
- ANP (1-28)
Atrial Natriuretic Factor Precursors- Atrial Natriuretic Factor Precursors
- Prepro-Cardiodilatin-Atrial Natriuretic Factor
- Prepro Cardiodilatin Atrial Natriuretic Factor
- ANF Precursors
- Cardiodilatin Precursor
- Prepro-ANP
- Prepro ANP
- Prepro-CDD-ANF
- Prepro CDD ANF
gamma-Atrial Natriuretic Peptide- gamma-Atrial Natriuretic Peptide
- gamma Atrial Natriuretic Peptide
- ANF (1-126)
- Proatrial Natriuretic Factor
- Pronatriodilatin
- Atriopeptin 126
- Cardionatrin IV
- Atrial Natriuretic Factor Prohormone
- Atrial Natriuretic Factor (1-126)
- Atrial Natriuretic Peptide (1-126)
- ANP (1-126)
- Atrial Pronatriodilatin
- Atriopeptin Prohormone (1-126)
- Atriopeptigen
- Pro-ANF
- Pro ANF
- ProANF
|
Below are MeSH descriptors whose meaning is more general than "Atrial Natriuretic Factor".
Below are MeSH descriptors whose meaning is more specific than "Atrial Natriuretic Factor".
This graph shows the total number of publications written about "Atrial Natriuretic Factor" by people in this website by year, and whether "Atrial Natriuretic Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 1 | 4 |
| 2004 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Atrial Natriuretic Factor" by people in Profiles.
-
Huang Y, Wang LL, Liu ZB, Chen C, Ren X, Luo AT, Ma JH, Antzelevitch C, Barajas-Mart?nez H, Hu D. Underlying mechanism of atrial fibrillation-associated Nppa-I137T mutation and cardiac effect of potential drug therapy. Heart Rhythm. 2024 02; 21(2):184-196.
-
Kornej J, B?ttner P, Sommer P, Dagres N, Dinov B, Schumacher K, Bollmann A, Hindricks G. Prediction of electro-anatomical substrate using APPLE score and biomarkers. Europace. 2019 Jan 01; 21(1):54-59.
-
Seew?ster T, B?ttner P, Nedios S, Sommer P, Dagres N, Schumacher K, Bollmann A, Hilbert S, Jahnke C, Paetsch I, Hindricks G, Kornej J. Association Between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical Substrate and NT-proANP Levels in Atrial Fibrillation. J Am Heart Assoc. 2018 10 02; 7(19):e009427.
-
B?ttner P, Schumacher K, Dinov B, Zeynalova S, Sommer P, Bollmann A, Husser D, Hindricks G, Kornej J. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes. Heart Rhythm. 2018 08; 15(8):1132-1137.
-
Alqahtani MF, Smith CM, Weiss SL, Dawson S, Ralay Ranaivo H, Wainwright MS. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein. PLoS One. 2016; 11(4):e0153645.
-
Rajagopal K, Saha P, Mohammed I, Sanchez PG, Li T, Wu ZJ, Griffith BP. Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction. J Thorac Cardiovasc Surg. 2015 Nov; 150(5):1332-41.
-
Lee R, Xu B, Rame JE, Felkin LE, Barton P, Dries DL. Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure. J Am Heart Assoc. 2014 Dec; 3(6):e001104.
-
Morita Y, Kohsaka S, Oshima K, Yoshikawa T, Fukuda K. Use of carperitide infusion for acutely decompensated heart failure. Crit Care. 2012 Jan 25; 16(1):406.
-
Sch?nrath K, Pan W, Klein-Szanto AJ, Braunewell KH. Involvement of VILIP-1 (visinin-like protein) and opposite roles of cyclic AMP and GMP signaling in in vitro cell migration of murine skin squamous cell carcinoma. Mol Carcinog. 2011 May; 50(5):319-33.
-
Rockwood DN, Akins RE, Parrag IC, Woodhouse KA, Rabolt JF. Culture on electrospun polyurethane scaffolds decreases atrial natriuretic peptide expression by cardiomyocytes in vitro. Biomaterials. 2008 Dec; 29(36):4783-91.